NEWS


News & events

our last paper

In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline.

In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline.

Pereira MF, Shyti R, Testa G
Jun , 2024

highlight

18 PhD positions in System Medicine are now opened at the IEO!

18 PhD positions in System Medicine are now opened at the IEO!

DEADLINE: 27th OF JULY 2024

highlight

È online il sito Health Big Data!

È online il sito Health Big Data!

Our SCIENCE


Research & technology

Our science
Principal Investigators
Technological Units
Clinical Technoshots
Translational Research Programs
Technology Transfer Office (IEO-TT)

Our MENTORING


Education & training

Our mentoring
Undergraduate Students
PhD Students
Postdoctoral Fellows
Technicians

Our ALLIANCES


Partners & Networks

JOIN us


Job Opportunities: ongoing ads

Technologists

Posted: 11/06/2024

Technologists

Posted: 11/06/2024

Technicians

Posted: 16/05/2024

Technicians

Posted: 14/05/2024

In the past 20 years since DEO foundation, many scientists have started their career and matured professionally in the department. This has created a large community of scientists that, even though are now working in different institutes in the world, keep pleasant memories and a strong tie with their experience in IEO. In 2018, DEO organized the first Alumni meeting, where 50 ex-PhD students, post-doctoral fellows and Group Leaders of IEO, now Principal Investigators or Institute Directors worldwide, met and renewed their pleasure to interact and discuss science.

READ
Iros Barozzi

Iros Barozzi

VIEW DETAILS

SUPPORT us


The Italian Government offers tax payers the opportunity of devolving 0.5% of their taxes to not for profit organizations. This option is known as the “Cinque per mille” (5x1000).

On the occasion of the payment of your income tax return by 730, or CUD in Italy, you can sign up to donate 5x1000 of your tax in favor of the European Institute of Oncology (IEO), thus sustaining research, innovation and cure.